A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

  • Observational
  • Not Recruiting
  • NCT02932449
Eligibility Details Visit Clinicaltrials.gov

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Gender
All

Age Group
18 Years and up

Accepting Healthy Volunteers?
No

Inclusion Criteria:

         - Adult patients (age 18 or older) being treated or managed for PBC

        Exclusion Criteria:

         - Inability to provide written informed consent

         - Simultaneous enrollment in another prospective registry or clinical trial or study where PBC treatment outcomes are reported, except where approved or conducted as an adjunct project of TARGET-PBC

At a Glance

National Government IDNCT02932449

IRB#IRB16-1686

Lead SponsorTarget PharmaSolutions, Inc.

Lead PhysicianKapuluru Reddy

Collaborator(s)N/A

EligibilityAll
18 Years and up
Not Recruiting